OraSure Technologies Inc. (NASDAQ:OSUR) traded at a new 52-week low today of $9.26. Approximately 1 million shares have changed hands today, as compared to an average 30-day volume of 1.1 million shares.
There is potential upside of 6.8% for shares of OraSure Technologies Inc. based on a current price of $9.37 and an average consensus analyst price target of $10.01.
OraSure Technologies Inc is engaged in the development, manufacturing, and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. Its reportable segments are Diagnostics business which consists of the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using proprietary technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Molecular Solutions business that manufactures and sells kits that are used to collect, stabilize, transport and store biological samples of genetic material for molecular testing.
OraSure Technologies Inc. share prices have moved between a 52-week high of $19.75 and the current low of $9.26 and are currently at $9.37 per share.
Receive IBN Spotlights - "Bite Size" Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer